Bayer Hits Abbott With Patent Suit Over Humira

Law360 (December 29, 2008, 12:00 AM EST) -- Bayer HealthCare LLC has sued Abbott Laboratories, alleging that Abbott's hugely popular arthritis drug Humira infringes a Bayer patent.

In a complaint filed Wednesday in the U.S. District Court for the Eastern District of Texas, Bayer accused Abbott of infringing U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” by selling Humira in the U.S.

The '407 patent, issued in 1997, describes an antibody that binds to human tumor necrosis factor alpha, a compound involved in inflammatory diseases.

Humira, which was approved by the U.S. Food and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.